消化和腸道藥物市場機會、成長動力、產業趨勢分析和預測 2024 - 2032

Digestive and Intestinal Remedies Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: 2024年09月02日 | 出版商:

Global Market Insights Inc. | 英文 123 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年，全球消化和腸道藥物市場價值為 195 億美元，預計 2024 年至 2032 年複合年成長率為 3.5%。例如，加拿大消化健康基金會報告稱，近 17% 的加拿大成年人患有胃食道逆流。症狀包括胸痛、慢性咳嗽、胃灼熱、睡眠呼吸中止症、逆流和打嗝。大量攝入加工食品和超重會導致這種情況，從而導致對消化和腸道藥物的更高需求。

胃食道逆流症、腸躁症(IBS)、消化性潰瘍、便秘、腹瀉、發炎性腸道疾病(IBD) 和胃腸炎等疾病通常需要消化酵素、止瀉藥物和纖維補充劑等治療方法。這些療法對於治療這些疾病至關重要。這些療法的非處方藥供應提高了它們的採用率。消化藥物細分市場佔據主導地位，到 2023 年將產生 103 億美元的收入。

這些配方可有效緩解胃灼熱、消化不良、腹脹、便秘和腹瀉等症狀。許多消化藥物，如制酸劑和質子幫浦抑制劑 (PPI)，都可以在櫃檯購買，無需處方即可立即緩解。廣泛的研究和悠久的使用歷史鞏固了這些藥物在短期和長期應用中安全性的聲譽。消化和腸道藥物的市場佔有率分為線下和線上分銷管道。

市場範圍
開始年份	2023年
預測年份	2024-2032
起始值	195 億美元
預測值	267 億美元
複合年成長率	3.5%

預計到 2032 年，線上市場將達到 60 億美元。這些平台 24/7 運行，確保隨時可以獲得補救措施，這對於那些在正常時間之外出現症狀的人來說是有益的。

網路已成為健康資訊的主要來源，引導消費者在線上研究消化健康問題和補救措施。這種意識的提高影響了他們在數位平台上的購買決策。

2023 年，美國在消化和腸道藥物市場中佔了 74 億美元的佔有率。美國領先公司專注於開發先進配方，特別是在質子幫浦抑制劑（PPI）和益生菌等領域，強調更持久的效果、減少副作用和增強功效。這一重點預計將提振美國市場。美國準備好保持其在市場的主導地位，推動成長和創新。

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

Abbott Laboratories
Bayer AG
CH Boehringer Sohn AG & Co. KG.
China Resources Pharmaceutical Group Limited
Eli Lilly and Company
GlaxoSmithKline plc
Johnson & Johnson
Menarini Group
Merck & Co, Inc.
Pfizer Inc.
The Procter & Gamble Company
Reckitt Benckiser Group plc (RB)
Sanofi SA
Taisho Pharmaceutical Holdings Co., Ltd.
Takeda Pharmaceutical Company Limited

簡介目錄

Product Code: 11167

The Global Digestive And Intestinal Remedies Market was valued at USD 19.5 billion in 2023 and is projected to grow at a CAGR of 3.5% from 2024 to 2032. The increasing prevalence of gastrointestinal diseases drives this market. For instance, the Canadian Digestive Health Foundation reports that nearly 17% of Canadian adults suffer from GERD. Symptoms include chest pain, chronic cough, heartburn, sleep apnea, regurgitation, and belching. High intake of processed foods and being overweight contribute to this condition, leading to a higher demand for digestive and intestinal remedies.

Conditions such as GERD, irritable bowel syndrome (IBS), peptic ulcers, constipation, diarrhea, inflammatory bowel disease (IBD), and gastroenteritis often require remedies like digestive enzymes, anti-diarrheal medications, and fiber supplements. These remedies are essential for managing these ailments. The over-the-counter availability of these remedies boosts their adoption rate. The digestive medicines segment dominated the market, generating USD 10.3 billion in revenue in 2023. Digestive medicines, including both pharmaceutical and over-the-counter drugs, are formulated to alleviate a range of digestive issues.

These formulations effectively relieve symptoms such as heartburn, indigestion, bloating, constipation, and diarrhea. Many digestive medicines, like antacids and proton pump inhibitors (PPIs), are available over the counter, allowing individuals to access them for immediate relief without a prescription. Extensive research and a long history of use have cemented the reputation of these medicines for safety in both short-term and long-term applications. The market share of digestive and intestinal remedies is segmented into offline and online distribution channels.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$19.5 Billion
Forecast Value	$26.7 Billion
CAGR	3.5%

The online segment is anticipated to reach USD 6 billion by 2032. Online platforms enable consumers to purchase digestive and intestinal remedies from home, eliminating the need for a pharmacy visit. These platforms operate 24/7, ensuring remedies are accessible anytime, which is beneficial for those experiencing symptoms outside regular hours.

The internet has become a primary source of health information, leading consumers to research digestive health issues and remedies online. This increased awareness influences their purchasing decisions on digital platforms.The rise in telemedicine and online consultations allows healthcare providers to prescribe digestive remedies, which patients can promptly purchase online, further fueling market growth.

In 2023, the U.S. accounted for a significant USD 7.4 billion share of the digestive and intestinal remedies market. Leading companies in the U.S. focus on developing advanced formulations, particularly in areas like proton pump inhibitors (PPIs) and probiotics, emphasizing longer-lasting effects, reduced side effects, and enhanced efficacy. This focus is expected to bolster the U.S. market.Social media, health blogs, and online forums play a crucial role in educating consumers about digestive health, fostering informed purchasing decisions. The U.S. is poised to maintain its dominance in the market, driving both growth and innovation.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rise in incidence of gastrointestinal disorders
  - 3.2.1.2 Growing demand for related over-the-counter products
  - 3.2.1.3 Changes in natural food habits
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Availability of alternative therapies for gastrointestinal diseases
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Digestive medicines
5.3 Remedies against gastrointestinal complaints
5.4 Natural and synthetic agents

Chapter 6 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Adult
6.3 Pediatric

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Offline
7.3 Online

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa